Trial Profile
Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Exploratory Study Investigating the Effects of [Vortioxetine] Lu AA21004 on Cognition and BOLD fMRI Signals in Subjects Remitted From Depression and Controls
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Jul 2019
Price :
$35
*
At a glance
- Drugs Vortioxetine (Primary)
- Indications Cognition disorders; Depression; Major depressive disorder
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors Lundbeck A/S
- 01 Sep 2015 Results presented at the 28th Annual Congress of the European College of Neuropsychopharmacology
- 01 Sep 2015 Results presented at the 28th Annual Congress of the European College of Neuropsychopharmacology
- 01 Sep 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.